Have a personal or library account? Click to login
Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults Cover

Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults

Endocrine Regulations
Volume 59 (2025): Issue 1 (January 2025)
By: Ali R. Khan,  Gennifer Wahbah Makhoul and  Mukaila A. Raji  
Open Access
|Dec 2025
DOI: https://doi.org/10.2478/enr-2025-0030 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 260 - 264
Published on: Dec 12, 2025
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
GLP-1 receptor agonists,
mirtazapine,
gastrointestinal side effects,
diabetes,
older adults,
cognitive impairment
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2025 Ali R. Khan, Gennifer Wahbah Makhoul, Mukaila A. Raji, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 59 (2025): Issue 1 (January 2025)Next article